Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-06-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
第四届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 15th meeting of the 4th Board of Directors of 华蓝集团股份公司. It details the meeting date, attendance, agenda items discussed, voting results, and mentions revisions to various internal management systems and policies. The document does not contain financial statements or detailed financial performance data. It is a disclosure about board decisions and governance matters, specifically about board meeting resolutions and internal policy amendments. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management.
2023-06-26 Chinese
对外信息报送与使用管理制度（2023年6月）
Governance Information Classification · 95% confidence The document is a detailed internal management system for external information reporting and usage by 华蓝集团股份公司, including procedures for handling confidential and insider information, approval processes, and legal responsibilities. It references laws and regulations related to securities and information disclosure but does not contain any financial statements, earnings data, or report content. It is a governance and compliance document outlining internal rules and procedures rather than a financial report or announcement. The document length is 3664 characters, which is relatively short and does not present any financial data or results. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-06-26 Chinese
信息披露暂缓与豁免业务内部管理制度（2023年6月）
Governance Information Classification · 95% confidence The document is titled as an internal management system for information disclosure delay and exemption by 华蓝集团股份公司, dated June 2023. It outlines internal procedures, definitions, and approval processes related to delaying or exempting information disclosure to comply with regulatory requirements. There are no financial statements, earnings data, or investor presentations. It is a governance-related internal policy document rather than a report or announcement of financial results or corporate actions. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The content aligns best with Governance Information (CGR), which covers internal rules and governance practices.
2023-06-26 Chinese
印章使用管理制度（2023年6月）
Regulatory Filings Classification · 95% confidence The document is a detailed internal management system for the use and control of company seals (印章使用管理制度) issued by 华蓝集团股份公司. It outlines procedures, responsibilities, and penalties related to seal usage within the company and its subsidiaries. There is no indication of financial data, regulatory filings, shareholder information, or any report related to financial performance or governance disclosures typically found in filings like Annual Reports, Interim Reports, or Governance Information. The document is a company internal policy or procedural manual rather than a regulatory or financial filing. It does not fit into any of the specific financial or regulatory filing categories provided. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories.
2023-06-26 Chinese
内幕信息知情人登记管理制度（2023年6月）
Governance Information Classification · 95% confidence The document is titled '内幕信息及知情人登记管理制度' which translates to 'Insider Information and Insider Registration Management System'. It is a detailed internal policy document outlining the management, confidentiality, and registration of insider information and insiders within the company. The content includes definitions, scope, responsibilities, confidentiality measures, registration procedures, and disciplinary actions related to insider information. There is no indication that this is a financial report, earnings release, regulatory filing, or any announcement related to shareholder meetings or capital changes. It is a governance-related internal control document focused on compliance with securities laws and insider information management. Therefore, the most appropriate classification is Governance Information (CGR). The document length (6896 characters) and detailed procedural content support this classification with high confidence.
2023-06-26 Chinese
太平洋证券关于华蓝集团股份公司部分募投项目延期的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the delay of certain fundraising investment projects by a listed company. It discusses the use and management of funds raised from an IPO, project progress, reasons for delay, and the approval process by the board, supervisory committee, and independent directors. It references regulatory guidelines related to fundraising and project management. The document is not a full annual or interim financial report, nor is it an earnings release or a call transcript. It is not a simple announcement or a certification letter but a formal verification opinion related to fundraising project delays. This fits best under the category of Regulatory Filings (RNS), as it is a regulatory compliance-related disclosure that does not fit into other specific categories like capital update or audit report.
2023-06-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.